Infusion of hydroxyethyl starch-containing fluids.

نویسندگان

  • C Aubron
  • R Bellomo
چکیده

The infusion of hydroxyethylstarch (HES) containing fluids has been extremely common worldwide over the last decade. Until recently, HES was probably the most commonly prescribed colloidal preparation in the world. Such prescription continued despite concerns that starch molecules might accumulate in vital organs and that starch preparations might decrease the coagulability of blood. These concerns have led to two pivotal multicenter double-blind controlled trials in critically ill patients, one conducted in Scandinavia in septic Intensive Care Unit (ICU) patients, and the other conducted in Australia and New Zealand in a heterogeneous group of ICU patients. Both studies found that the infusion of HES increased the risk of needing renal replacement therapy. In addition, the Scandinavian study found that HES increased mortality. Subsequent meta-analyses have confirmed these findings. In response to such strong evidence, over the last few weeks, the Food and Drug Administration has issued a major warning and, in Europe, the EMA suspended the marketing authorization for HES. At least in Europe, the clinical story of HES seems to have come to an end.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Fluid Therapy in Thoracic Surgery: A Zero-Balance Target is Always Best!

Clinical studies including various types of surgical procedures have clearly shown an association between high perioperative fluids infusion and poor clinical outcome as expressed by composite mortality-morbidity endpoints (1-3). Overzealous fluid infusion promotes wound infections/dehiscence, anastomotic leakage and cardiac overload. Besides these quantitative aspects, fluid composition also d...

متن کامل

The effect of 6% hydroxyethyl starch and desmopressin infusion on von Willebrand factor: ristocetin cofactor activity.

Hydroxyethyl starch is commonly used as a plasma volume expander in the surgical patient. Although it is generally considered a safe plasma substitution, some reports of an acquired von Willebrand's disease-like syndrome have been documented. To examine this further, von Willebrand factor: ristocetin cofactor activity (RCoF) was measured in two groups of patients perioperatively, following hydr...

متن کامل

Antioxidant potential of i.v. fluids.

In acute clinical settings where there may be a role for antioxidant therapy, patients receive large amounts of i.v. fluids which may have antioxidant activity. To investigate such effects the antioxidant capacity of nine i.v. fluids was measured (Gelofusine, Haemaccel, 20% mannitol, 4.5% human albumin solution, fresh frozen plasma, aprotinin, N-acetylcysteine and two hydroxyethyl starch soluti...

متن کامل

Influence of fluid infusion associated with high-volume blood loss on plasma propofol concentrations.

BACKGROUND It is common clinical practice to use fluid infusion to manage high-volume blood loss until a blood transfusion is performed. The authors investigated the influence of fluid infusion associated with blood loss on the pseudo-steady state propofol concentration. METHODS Twenty-seven swine were assigned to a lactated Ringer's solution group, a hydroxyethyl starch group, or a threefold...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Minerva anestesiologica

دوره 79 9  شماره 

صفحات  -

تاریخ انتشار 2013